Additionally, Rasal2 is also reported to negatively modulate angiogenesis in renal cell carcinoma [15], suggesting the potential role of Rasal2 in regulating vascular pathological and physiological functions. This evidence concerns the gene RASAL2 and renal cell carcinoma.